{'Year': '2018', 'Month': 'Oct'}
Pharmacogenetic content of commercial genome-wide genotyping arrays.
We have evaluated the pharmacogenetic content of commercial human genome-wide genotyping arrays, as it is a critical determinant to enabling pharmacogenomic discoveries.